Update: Routine screening for antibodies to human immunodeficiency virus, civilian applicants for U.S. military service and U.S. Armed Forces, active and reserve components, January 2009-June 2014.
Publication Status: Published
Sponsoring Organization: Defense Health Agency (formerly TRICARE Management Activity)
Sponsoring Office: Armed Forces Health Surveillance Center
Congressionally Mandated: No
Funding Source: Defense Health Agency (formerly TRICARE Management Activity)
Release Date/Publication: August 01, 2014
Principle Investigator Status: Government
Primary DoD Data Source: Defense Medical Surveillance System
Secondary DoD Data Source:
Abstract
This report contains an update through June 2014 of the results of routine screening for antibodies to the human immunodeficiency virus (HIV) among civilian applicants for military service and among members of the active and reserve components of the U.S. Armed Forces. Seroprevalences among civilian applicants in 2013 and the first half of 2014 (0.19 and 0.15 per 1,000 tested, respectively) were markedly lower than in 2012 (0.27 per 1,000 tested). In nearly every component of every service, seroprevalences in 2013 and 2014 were either similar or lower than in prior years; however, in the Army National Guard, seroprevalences increased each year and approximately doubled from 2010 (0.18 per 1,000 tested) to 2013-2014 (0.35-0.41 per 1,000 tested). Among active and reserve component service members, seroprevalences continue to be higher among Army and Navy members and males than their respective counterparts.
Citation:
AFHSC. Update: Routine screening for antibodies to human immunodeficiency virus, civilian applicants for U.S. military service and U.S. Armed Forces, active and reserve components, January 2009-June 2014. MSMR. 2014 Aug;21(8):16-22.